Dylan Hansen

St. Vincent's Hospital, Melbourne
Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Predictive Accuracy of Serum N-Terminal Pro-B-Type Natriuretic Peptide Alone and in Combination with Respiratory Function Tests to Identify Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).

Predictive Accuracy of Serum N-Terminal Pro-B-Type Natriuretic Peptide Alone and in Combination with Respiratory Function Tests to Identify Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).

Journal: Diagnostics (Basel, Switzerland)

Published: March 11, 2026

Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study.

Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study.

Journal: The Australasian journal of dermatology

Published: March 02, 2026

A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension-Results From the SPHInX Study.

A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension-Results From the SPHInX Study.

Journal: Pulmonary circulation

Published: March 01, 2026

Factor Analysis to Determine Subgroups of Gastrointestinal Symptoms in Systemic Sclerosis.

Factor Analysis to Determine Subgroups of Gastrointestinal Symptoms in Systemic Sclerosis.

Journal: The Journal of rheumatology

Published: January 12, 2026

Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement.

Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement.

Journal: Rheumatology (Oxford, England)

Published: November 11, 2025

Characteristics and outcomes of male participants in the Australian Scleroderma Cohort Study (ASCS).

Characteristics and outcomes of male participants in the Australian Scleroderma Cohort Study (ASCS).

Journal: Arthritis care & research

Published: November 04, 2025

Increased incidence of sudden cardiac death in systemic sclerosis: data from a nationwide cohort study.

Increased incidence of sudden cardiac death in systemic sclerosis: data from a nationwide cohort study.

Journal: Seminars in arthritis and rheumatism

Published: September 23, 2025

High levels of Vascular Cell Adhesion Molecule 1 associate with a "vasculopathic" phenotype in systemic sclerosis with higher mortality.

High levels of Vascular Cell Adhesion Molecule 1 associate with a "vasculopathic" phenotype in systemic sclerosis with higher mortality.

Journal: Rheumatology (Oxford, England)

Published: July 17, 2025

Mucocutaneous disease activity and damage accrual in systemic lupus erythematosus: analyses from the Asia-Pacific Lupus Collaboration longitudinal cohort study.

Mucocutaneous disease activity and damage accrual in systemic lupus erythematosus: analyses from the Asia-Pacific Lupus Collaboration longitudinal cohort study.

Journal: Arthritis care & research

Published: June 25, 2025

Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia-Pacific Lupus Collaboration Longitudinal Cohort Study.

Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia-Pacific Lupus Collaboration Longitudinal Cohort Study.

Journal: Arthritis care & research

Published: June 25, 2025

Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.

Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.

Journal: Canadian respiratory journal

Published: June 04, 2025

Clinical associations of worsening physical function as measured by HAQ-DI scores in systemic sclerosis.

Clinical associations of worsening physical function as measured by HAQ-DI scores in systemic sclerosis.

Journal: Journal of scleroderma and related disorders

Published: May 06, 2025

Showing 1-12 of 64

Last Updated: 09/26/2026